RK

Rani Kumari

Active Director Director DIN 09366819
DIN 09366819 First appointment Oct 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Rani Kumari

Data last updated:

Rani Kumari is a Director at Arsons Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Arsons Pharmaceuticals Private Limited reported revenue of ₹25.9 Lakh (FY 2023).

DIN 09366819
Primary Designation Director
Industry Pharma
First Appointment 21 Oct 2021
Oldest Company Age 5 yrs
Largest company Arsons Pharmaceuticals Private Limited · ₹25.9 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Oct 20212021₹25.9 Lakh (FY 2023)Active

Board colleagues of Rani Kumari

NameDINCompanyDesignation
Bittu Kumar09366820Arsons Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arsons Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rani Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rani Kumari

Rani Kumari currently holds 1 directorship: Arsons Pharmaceuticals Private Limited (Director, since 21 Oct 2021, revenue ₹25.9 Lakh (FY 2023)).

Rani Kumari was first appointed on 21 Oct 2021 as Director at Arsons Pharmaceuticals Private Limited.

The current boards of Rani Kumari's companies include Bittu Kumar (Arsons Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available